Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6650
+0.0350 (2.15%)
NASDAQ · Last Trade: Mar 27th, 3:51 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors